Wegener's Granulomatosis Clinical Trials

• Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
  ClinicalTrials.gov Identifier: NCT00104299 - Recruiting
  Vasculitis; Wegener's Granulomatosis
  
• An Open Label Pilot Study Examining the Use of Rituximab in Patients with Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
  ClinicalTrials.gov Identifier: NCT00072592 - Completed
  Wegener's Granulomatosis
  
• Comparison of Treatments to Maintain Disease Remission in Patients with Wegener's Granulomatosis and Related Vasculitis Syndromes
  ClinicalTrials.gov Identifier: NCT00004567 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
  ClinicalTrials.gov Identifier: NCT00103792 - Recruiting
  Wegener's Granulomatosis; Vasculitis
  
• Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00468208 - Not yet recruiting
  Wegener's Granulomatosis
  
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients with Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001761 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Treatment of Wegener's Granulomatosis with Cyclophosphamide
  ClinicalTrials.gov Identifier: NCT00001155 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Analysis of Bronchial Tissue and Fluid in Patients with Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001541 - Completed
  Inflammation; Vasculitis; Wegener's Granulomatosis
  
• Determining Disease Activity Biomarkers in Individuals With Wegener's Granulomatosis and Microscopic Polyangiitis
  ClinicalTrials.gov Identifier: NCT00315393 - Recruiting
  Wegener's Granulomatosis; Microscopic Polyangiitis
  
• Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
  ClinicalTrials.gov Identifier: NCT00001764 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Daclizumab to Treat Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00040248 - Completed
  Wegener's Granulomatosis
  
• Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00530075 - Completed
  Wegener's Granulomatosis
  
• Etanercept to Treat Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001901 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
  ClinicalTrials.gov Identifier: NCT00001473 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Etanercept for Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00005007 - Completed
  Wegener's Granulomatosis
  
• Steroids and Methotrexate to Treat Systemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00001256 - Completed
  Inflammation; Vasculitis; Wegener's Granulomatosis
  
• WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
  ClinicalTrials.gov Identifier: NCT00349674 - Active, not recruiting
  Systemic Wegener's Granulomatosis
  
• Assessment of Lung Inflammation in Patients with Atopic Asthma Using Positron Emission Tomography
  ClinicalTrials.gov Identifier: NCT00001759 - Completed
  Asthma; Hypersensitivity; Lung Diseases; Wegener's Granulomatosis
  
• Diagnostic Effectiveness of Virtual Bronchoscopy
  ClinicalTrials.gov Identifier: NCT00001515 - Completed
  Bronchogenic Carcinoma; Chronic Granulomatous Disease; Job's Syndrome; Mycobacterium Infection; Wegener's Granulomatosis
  
• Treatment and Natural History Study of Lymphomatoid Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001379 - Recruiting
  Lymphomatoid Granulomatosis
  
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
  ClinicalTrials.gov Identifier: NCT00307593 - Completed
  Wegener's Granulomatosis; Churg-Strauss Syndrome; Microscopic Polyangiitis
  
• Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
  ClinicalTrials.gov Identifier: NCT00430105 - Completed
  ANCA Associated Systemic Vasculitis; Wegener's Granulomatosis; Microscopic Polyangiitis
  
• Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated with the Epstein Barr Virus
  ClinicalTrials.gov Identifier: NCT00006340 - Completed
  Cancer; grade I lymphomatoid granulomatosis; grade II lymphomatoid granulomatosis; recurrent grade I lymphomatoid granulomatosis; ...
  
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
  ClinicalTrials.gov Identifier: NCT00006055 - Active, not recruiting
  Purpura, Schoenlein-Henoch; Graft Versus Host Disease; Anemia, Hemolytic, Autoimmune; Rheumatoid Arthritis; Churg-Strauss Syndrome; ...
  
• Long-Term Effects of Iodine I131 Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00098566 - Active, not recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; Quality of Life
  
• SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101244 - Active, not recruiting
  adult Hodgkin's lymphoma; adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; ...
  
• Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079261 - Active, not recruiting
  adult diffuse large cell lymphoma; adult lymphomatoid granulomatosis; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ...
  
• Biological Therapy and Combination Chemotherapy in Treating Patients With Lymphomatoid Granulomatosis
  ClinicalTrials.gov Identifier: NCT00018993 - Recruiting
  Lymphoma; Precancerous/Nonmalignant Condition
  
• Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
  ClinicalTrials.gov Identifier: NCT00093704 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent adult Burkitt's lymphoma; post-transplant lymphoproliferative disorder; ...
  
• Monoclonal Antibody hA20 in Treating Patients With Refractory Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00112970 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin''s lymphoma; indolent or aggressive adult non-Hodgkin''s lymphoma
  
• Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
  ClinicalTrials.gov Identifier: NCT00307671 - Recruiting
  Vasculitis; Wegener’s Granulomatosis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Polyarteritis Nodosa
  
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
  ClinicalTrials.gov Identifier: NCT00138983 - Completed
  Rheumatoid Arthritis; Polymyalgia Rheumatica; Giant Cell Arteritis; Polymyositis; Wegener''s granulomatosis
  
• IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00307645 - Terminated
  ANCA Associated Systemic Vasculitis Including Wegener’s; Granulomatosis and Microscopic Polyangiitis and; Renal Limited Vasculitis